QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 therapeuticsmd-q1-eps-007-up-from-024-yoy

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.07) per share. This is a 70.83 percent increase over losses of $(...

 therapeuticsmd-q3-eps-013-misses-005-estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0....

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 cantor-fitzgerald-reiterates-neutral-on-therapeuticsmd-maintains-5-price-target

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and maintains $5 price target.

 therapeuticsmd-q2-eps-024-misses-007-estimate-sales-from-cont-ops-40000k-miss-50000k-estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0....

 cigna-is-out-with-a-new-coverage-policy-stating-that-therapeuticsmd-imvexxy-is-now-covered-effective-1124-but-just-disclosed

https://static.cigna.com/assets/chcp/pdf/coveragePolicies/pharmacy/ip_0216_coveragepositioncriteria_vaginal_estrogen_products.pdf

 cantor-fitzgerald-reinstates-neutral-on-therapeuticsmd-announces-5-price-target

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

 therapeuticsmd-q3-sales-2092m-down-from-2541m-yoy

TherapeuticsMD (NASDAQ:TXMD) reported $20.92 million in sales this quarter. This is a 17.67 percent decrease over sales of $25....

 therapeuticsmd-announces-7m-private-placement

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

 12-health-care-stocks-moving-in-tuesdays-after-market-session

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The comp...

 therapeuticsmd-appoints-dr-brian-bernick-and-mr-mark-glickman-as-interim-co-chief-executive-officers

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

 looking-into-therapeuticsmds-return-on-capital-employed

According to Benzinga Pro, during Q2, TherapeuticsMD (NASDAQ:TXMD) earned $112.28 million, a 329.05% increase from the precedin...